Article

Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell lines

2024-08-26

Abstract excerpt

<title>Abstract</title> <p>Acute myeloid leukemia (AML) is the most prevalent type of leukemia in adults. Its heterogeneity, both between patients and within the same patient, is often a factor contributing to poor treatment outcomes. Despite advancements in AML biology and medicine in general, the standard AML treatment, the combination of cytarabine and daunorubicin, has remained the same for decades. Combinati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 884f30ca-1f1b-594a-be83-0fce47d85e4a
DOI: 10.21203/rs.3.rs-4159724/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell linesDOI 10.21203/rs.3.rs-4159724/v1Read

Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell linesSemantic proximity Read

Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.Semantic proximity Read

Venetoclax and Hypomethylating Agent Combination in Myeloid Malignancies: Mechanisms of Synergy and Challenges of ResistanceSemantic proximity Read

Synergistic Effect of Chidamide and Venetoclax on Apoptosis in Acute Myeloid Leukemia Cells and Its MechanismSemantic proximity Read

Synergistic effect of chidamide and venetoclax on apoptosis in acute myeloid leukemia cells and its mechanismSemantic proximity Read

Identifying effective drug combinations for patients with acute myeloid leukemia.Semantic proximity Read

Patient-tailored design of AML cell subpopulation-selective drug combinationsSemantic proximity Read

Epigenetic therapy combinations in acute myeloid leukemia: what are the options?Semantic proximity Read

A statistical framework for defining synergistic anticancer drug interactionsSemantic proximity Read

Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid LeukemiaSemantic proximity Read

Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia TherapySemantic proximity Read